Hendrik was Vice President, Global Development Lead NTRK Program, SBU Oncology at Bayer Pharmaceuticals, and Medical Advisor at Nordic Biotech Advisors. Hendrik Nogai joined Ryvu Therapeutics in 2022.
Hendrik Nogai is currently Chief Medical Officer at Ryvu Therapeutics - View - Ryvu Therapeutics org chart
Create your alert
to follow the career of Hendrik Nogai.
In 2004, Hendrik Nogai completed a Doctor of Medicine at Ludwig Maximilian University of Munich.
They have also studied at Ludwig Maximilian University of Munich :
Find more alumni from Ludwig Maximilian University of Munich
Do you need to know more about Hendrik Nogai? More results.
Report an error
Update the org chart details of Hendrik Nogai.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.